AdvisorShares迷幻药主动型ETF PSIL 深 沪
已收盘 02-06 16:00:00 美东时间
16.51
+0.875
+5.60%
华盛通- 最 高16.63
- 今 开15.971
- 成交量 1.11万股
- 最 低 15.97
- 昨 收 15.6348
- 总市值 1956.40万
- 52周最高 19.9261
- 市盈率 静 --
- 换手率 0.94%
- 52周最低 7.8642
- 委 比 -81.82%
- 总股本 118.50万
- 历史最高 104.3816
- 量 比 0.56
- 振 幅 4.22%
- 历史最低 5.9573
- 每 手 1
- 风险率 3.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
2025-08-06 02:25
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
2025-05-25 04:11
5 ETFs That Beat Market Turmoil With Gains Last Week
Last week had Wall Street facing volatility, tech earnings disappointments, mixed labor data, and rising inflation fears. Gold hit record highs.
2025-02-11 00:05
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
2024-09-10 02:09
AdvisorShares Announces 1-For-10 Reverse Split Of ETF, Effective September 10, 2024
AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), has announced a reverse split of the issued and outstanding shares of the AdvisorShares Psychedelics ETF. The split will not change the
2024-08-31 04:16
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.
2024-06-06 03:26
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depress...
2024-03-30 00:43
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Th...
2024-03-21 02:49
Reported Earlier, 'Indiana Lawmakers Send Psilocybin Research Funding Bill To Governor' - Marijuana Moment
https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/ The Indiana legislature has sent a bill to the governor's desk that includes provisions to fund clinical research trials into psilocybin.
2024-03-15 00:42
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treati...
2024-03-05 02:48
